ABOUT TEAM FOX
1. An estimated five million people worldwide are living with Parkinson’s disease. In the United States, 60,000 new cases will be diagnosed this year alone.
2. Currently, there is no way to prevent or accurately predict who will develop Parkinson’s disease. There is no known cure, and currently available treatments temporarily mask symptoms while the disease continues to worsen.
3. Our mission: The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today.
4. Team Fox is the grassroots fundraising arm of The Michael J. Fox Foundation for Parkinson’s Research. Each year, more than 1,500 Team Fox members worldwide turn their passions and interests into unique fundraising events and athletic feats.
5. Since its inception in 2006, our Team Fox members have raised an astounding $16 million for Parkinson’s research.
6. To date, The Michael J. Fox Foundation has funded more than $285 million in Parkinson’s research, making us the largest private funder in this field. With seven on-staff PhDs, an MD and several business strategists, we have the expertise to evaluate the most promising research opportunities and to assess which areas hold the most promise for improving the treatment of PD.
7. Eighty-seven cents of every dollar we raise goes directly to our research program efforts. The Michael J. Fox Foundation is not chapter-based and has no endowment. We do everything we can to speed the intellectual and financial resources into the hands of scientists as quickly and efficiently as possible. We are in business to go out of business in our lifetime by finding a cure.
8. Sergey Brin, co-founder of Google, and Anne Wojcicki, co-founder of personal genetics company 23andMe, launched a $50-million Challenge designed to increase the Foundation’s capacity to do whatever it takes to speed a cure. The Brin Wojcicki Challenge will match, dollar for dollar, all new and increased gifts to MJFF, as well as gifts from donors who have not given since 2009 or earlier.
9. Fox Trial Finder, an online clinical trial matching tool, was created to increase the flow of willing participants – both people with Parkinson’s and participants who do not have the disease – into clinical trials that need them, speeding progress toward breakthrough therapies and a cure. Fox Trial Finder matches volunteers with trials and facilitates a connection with the trial team. By creating a profile, volunteers can receive alerts when new trials begin recruiting volunteers that match their criteria.
10. The Parkinson’s Progression Markers Initiative (PPMI) is the Foundation’s landmark, $45-million clinical study that aims to identify biomarkers of Parkinson’s disease progression. The study is actively recruiting newly diagnosed PD patients.
2. Currently, there is no way to prevent or accurately predict who will develop Parkinson’s disease. There is no known cure, and currently available treatments temporarily mask symptoms while the disease continues to worsen.
3. Our mission: The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today.
4. Team Fox is the grassroots fundraising arm of The Michael J. Fox Foundation for Parkinson’s Research. Each year, more than 1,500 Team Fox members worldwide turn their passions and interests into unique fundraising events and athletic feats.
5. Since its inception in 2006, our Team Fox members have raised an astounding $16 million for Parkinson’s research.
6. To date, The Michael J. Fox Foundation has funded more than $285 million in Parkinson’s research, making us the largest private funder in this field. With seven on-staff PhDs, an MD and several business strategists, we have the expertise to evaluate the most promising research opportunities and to assess which areas hold the most promise for improving the treatment of PD.
7. Eighty-seven cents of every dollar we raise goes directly to our research program efforts. The Michael J. Fox Foundation is not chapter-based and has no endowment. We do everything we can to speed the intellectual and financial resources into the hands of scientists as quickly and efficiently as possible. We are in business to go out of business in our lifetime by finding a cure.
8. Sergey Brin, co-founder of Google, and Anne Wojcicki, co-founder of personal genetics company 23andMe, launched a $50-million Challenge designed to increase the Foundation’s capacity to do whatever it takes to speed a cure. The Brin Wojcicki Challenge will match, dollar for dollar, all new and increased gifts to MJFF, as well as gifts from donors who have not given since 2009 or earlier.
9. Fox Trial Finder, an online clinical trial matching tool, was created to increase the flow of willing participants – both people with Parkinson’s and participants who do not have the disease – into clinical trials that need them, speeding progress toward breakthrough therapies and a cure. Fox Trial Finder matches volunteers with trials and facilitates a connection with the trial team. By creating a profile, volunteers can receive alerts when new trials begin recruiting volunteers that match their criteria.
10. The Parkinson’s Progression Markers Initiative (PPMI) is the Foundation’s landmark, $45-million clinical study that aims to identify biomarkers of Parkinson’s disease progression. The study is actively recruiting newly diagnosed PD patients.